|
El-Nasr Pharmaceutical Chemicals company had been constructed in 1960. The main objective to establish this company is to secure the Arab countries' strategic needs from pharmaceutical raw materials, chemicals and antibiotics that should be available permanently because of its strategic importance as a primary material needed by drug industry.
In May 1964, the Egyptian Ex- former President "Gamal Abdel Nasser" and the Soviet Ex-former President "Khruchouf" paid a visit to open the company that was considered as the primary nucleus planted for the city of medicine.
Thus; since then, the production of raw materials and basic chemicals for the pharmaceutical industry was realized for the first time in Egypt and the entire region.
Nasr Company for Pharmaceutical Chemicals is distinguished as the primary one in Egypt, Middle East and Africa because of its uniqueness in the production of organic and non-organic pharmaceuticals, veterinary medicine and veterinary raw materials, In addition to the production of parenteral and dialysis solutions , dialysis filters and the needed medical appliances necessary for packaging of large volume parenteral.
The company is keen to update and modernize their production lines regularly in accordance to the latest requirements of GMP and Egyptian Ministry of Healthguidelines.
The company is actively interested in exportation of its products to many Arab and African markets.
products company catalog
 download
products company profile
download
Board Members:
Dr/Hossam Ahmed Heba Manging Director
Dr/Ashraf Sameeh Sadek Chairman of the Board
Mr/ Salem sadek abo elmaati Member
Eng/Ali Bahaa Ali Member
Mr/ mohamed Abdel Maksoud mohamed Elected member
Audit Committee:
Dr/ Khaled shaban mansor Director
Mr/ Gamal Abdelghfar alioa Member
|
Company Main Indicators (in thousands of Egyptian Pounds) |
|
| Indicator |
2018-2019 |
2019-2020 |
2020-2021 |
| Net Operating Revenue |
465747 |
495629 |
429403 |
| Interest Expenses |
23040 |
15964 |
7582 |
| Net Income |
(80874) |
(104139) |
(164378) |
| Net Equity |
5984 |
(88039) |
(257271) |
| Working Capital |
(273346) |
(337265) |
(417763) |
| Total Investment |
777435 |
817511 |
821422 |
| Salaries |
208681 |
221620 |
208376 |
| Number of workers |
2283 |
2156 |
1979 | | | |